Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED Director's Dealing 2016

Oct 16, 2016

65387_rns_2016-10-16_c09d2244-7ed4-4002-96eb-5d0c4de55546.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Medical Developments International Limited ABN 14 106 340 667

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director David Williams
Date of last notice 7 October 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Lawn Views Pty Ltd – Indirect
Moggs Creek Pty Ltd – Indirect
Mr. David Williams (Trustee) - Indirect
Kidder Peabody Pty Ltd – Indirect
Ward Williams – Indirect
Saul Williams – Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Lawn Views Pty Ltd – 7,900,083
Moggs Creek Pty Ltd – 8,105,339
Mr. David Williams (Trustee) – 831,691
Kidder Peabody Pty Ltd – 1,008,208
Ward Williams – 23,637
Saul Williams – 8,582
Date of change 12 October 2016
No. of securities held prior to change 17,877,540
Class Fully Paid Ordinary Shares
Number acquired Nil
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil
No. of securities held after change 17,868,958
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Transfer of 8,582 ordinary fully paid
shares, previously held by Mr Williams as
trustee
for
Saul
Williams
to
Saul
Williams. Mr Williams is no longer
required to act as trustee as Saul Williams
has attained legal age.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance was
required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3